Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.
Conditions: Hypertension; Hypertension,Essential Interventions: Drug: fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg; Drug: Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg) Sponsor: Brainfarma Industria Química e Farmacêutica S/A Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials